The Role of Computed Tomography in the Phenotyping of COPD Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable disease that is characterized by respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases. the CT was used for classification of COPD patients into different phenotypes: phenotype A that has minimal emphysema with or without airway disease, phenotype E that has emphysema without airway disease, and finally phenotype M as a mixed form. The investigators aimed to to identify the phenotypes of COPD using radiologic data obtained by computed tomography. Moreover, this study will be designed to answer the questions about possible correlation between pulmonary function parameters and CT.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Phenotypes of COPD

NCT03432026

Chronic Obstructive Pulmonary Disease

UNKNOWN

Exhaled Breath Condensate Biomarkers and Cough in IPF

NCT02630940

Idiopathic Pulmonary Fibrosis

COMPLETED

Role of MSCT of Chest in Differentiation Between COPD Patients According to Their Smoking Status

NCT05475977

Patient Participation

UNKNOWN

A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)

NCT01219946

Chronic Obstructive Pulmonary Disease

COMPLETED

Evidence-based Analysis of Low-dose CT in Management of COPD

NCT02599883

Chronic Obstructive Pulmonary Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COPD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CT chest

All patients will undergo MSCT chest at both inspiratory and expiratory phases in supine position without any contrast media.

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All stable COPD patients that lastly confirmed to have the disease based on spirometry and past clinical history according to GOLD (2022).
* Age above 18 years.

Exclusion Criteria

* COPD patients associated with other chest diseases as collapse
* COPD patients associated with consolidation
* COPD patients unable to perform spirometry

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No